Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Shasqi, Inc.
Shasqi, Inc.
Sensei Biotherapeutics, Inc.
Leap Therapeutics, Inc.
Incyte Corporation
Leap Therapeutics, Inc.
Gradalis, Inc.
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Taproot Health
Kineta Inc.
SpeciCare
ImmunoFrontier, Inc.
Precision Therapeutics
Astellas Pharma Inc